Diligence memo · auto-generated · as of July 3, 2026
Visor Health Inc.
Visor Health Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Visor Health Inc. operates in Biotechnology, based in LOUISVILLE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Visor Health Inc. has raised $1.8M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.8M on 2025-01-07.
Most recent recorded round closed around 2025-01-07.
Valuation (modeled)modeled
Provath models Visor Health Inc. at approximately $6.4M (range $1.3M–$15M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.39× the median modeled value of Seed Biotechnology companies in 2025–2027 (99 peers) — value vs value, same stage and era. Within the normal band (139% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 18 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 26% of Biotechnology peers (4293 compared).
Modeled value ranks above 13% of those peers.
Closest niche peers: Carna Inc., NRX Pharmaceuticals, Inc., Vicora, Inc., MH3D, Inc., Oral Genome Corp..
Peoplefiled
3 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.